Skip to content
Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

HOW WE DO IT

Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung. We engineer them from patient samples and a range of pre-clinical species.

Don't miss out on our latest innovations: follow us on Linkedin

Author

Newcells Biotech

Published

24th April, 2019

Categories

Update

Get our latest updates straight to your inbox

Book a Call